Stay updated on Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.

Latest updates to the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedSite patch version updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check31 days agoChange DetectedNo additions or deletions detected; the page content appears unchanged between versions.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no changes to page content or functionality; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1; this maintenance change does not affect study content or available actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedGlossary controls were added (Show/Hide glossary) and the footer now includes 'Last Update Submitted that Met QC Criteria' with Revision: v3.4.0. Older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.3%

Stay in the know with updates to Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.